The best advice for cooks  

NEW ORLEANS (MedPage Today) — Patients with inflammatory bowel disease (IBD) have a two- to threefold increased risk of coronary artery disease (CAD) despite a lower prevalence of conventional CAD risk factors, data from a retrospective cohort showed. (source: medpagetoday.com) - Share on Twitter - Share on Facebook - RSS feeds and Widgets on Feedzilla.com

Here is the original:
DDW: IBD Linked to Increased CAD Risk (CME/CE, with audio) (source: medpagetoday.com)

Alvine Pharmaceuticals, Inc., announced the reporting of scientific data on the performance of its lead compound, ALV003, in a gastric simulation model. The data were presented at the 2010 Digestive Disease Week (DDW) meeting held in New Orleans, Louisiana… (source: Medical News Today) - Share on Twitter - Share on Facebook - RSS feeds and Widgets on Feedzilla.com

View original post here: 
Alvine Pharmaceuticals Presents Data On The Effects Of ALV003 In A Gastric Model That Predicts In Vivo Activity At DDW 2010 (source: Medical News Today)

The incidence of a certain type of gastric cancer has declined in the last 30 years for all age groups and races, except for whites 25 to 39 years of age, according to a study in the May 5 issue of JAMA… (source: Medical News Today) - Share on Twitter - Share on Facebook - RSS feeds and Widgets on Feedzilla.com

Go here to see the original:
Studies Examine Incidence Of Gastric Cancer, Benefits Associated With Chemotherapy Regimens (source: Medical News Today)

New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden’s University of Illinois laboratory. “There are so few therapies for persons with these ill…

Here is the original:
Help For Patients With Intestinal Failure, Malabsorptive Disorders (source: Medical News Today)

Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTCT offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster ..

See the original post: 
Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study (source: Medical News Today)

NEW ORLEANS (MedPage Today) — Patients with Crohn’s disease achieved durable remissions when treated with certolizumab pegol (Cimzia) regardless of prior exposure to a tumor necrosis factor (TNF) inhibitor, data from a long-term clinical study showed. (source: medpagetoday.com) - Share on Twitter - Share on Facebook - RSS and RSS Feed on Feedzilla.com

See the original post here:
DDW: Anti-TNF Agent Recaptures Response in Crohn’s Disease (CME/CE, with video) (source: medpagetoday.com)

ORLANDO (MedPage Today) — Patients with progressive pancreatic neuroendocrine tumors lived twice as long without progression when treated with sunitinib (Sutent) compared with placebo, data from a French clinical trial showed. (source: medpagetoday.com) - RSS and News widget on Feedzilla.com

Read the original here:
ASCO GI: Targeted Agent Slows Neuroendocrine Tumors (source: medpagetoday.com)

ORLANDO (MedPage Today) — Patients with advanced HER2-positive gastric cancer live longer, with no decline in quality of life, when trastuzumab (Herceptin) is added to chemotherapy, researchers reported here. (source: medpagetoday.com) - News widgets and RSS feeds on Feedzilla.com

Read more: 
ASCO GI: Survival Benefit with No New QoL Costs in Gastric Cancer (source: medpagetoday.com)

SAN DIEGO (MedPage Today) — Patients who’ve had bowel surgery and those with a history of Crohn’s disease may be at an increased risk of an incomplete capsule endoscopy, researchers said here. (source: medpagetoday.com) - RSS news feeds and Widgets on Feedzilla.com

More:
ACG: Bowel Surgery, Crohn’s Predict Capsule Endoscopy Problem (CME/CE) (source: medpagetoday.com)

VIENNA (MedPage Today) — Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with other insulins, researchers said here. (source: medpagetoday.com) - RSS news feeds and Widgets on Feedzilla.com

Read the original here:
EASD: Insulin Analogues, Cancer Linked, but No Causality Shown (source: medpagetoday.com)